2 documents

Read All
08:00 , Mar 2, 2009 |  BC Week In Review  |  Company News

Celerus sales and marketing update

Celerus launched 12 antibodies to be used on its Celerus Wave System for immunohistochemistry analysis. The antibodies target CD7, CD8 , neutral endopeptidase (MME) (NEP) (CD10) , CD30 , CD34, CD79a, c-kit proto-oncogene protein (KIT,...
Read More
08:00 , Feb 12, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Colorectal cancer Caudal type homeobox 1 (CDX1); keratin 20 (KRT20; CK20) In vitro studies suggest that enhancing CDX1 activity could help...
Read More